School of Medicine


Showing 1-24 of 24 Results

  • Francois Haddad

    Francois Haddad

    Clinical Professor, Medicine - Cardiovascular Medicine

    BioDr. Francois Haddad, MD is a Clinical Professor of Medicine that specializes in the field of cardio-vascular imaging, pulmonary hypertension, advanced heart failure and transplantation. Dr. Haddad has over 18 years of practice in the field of cardiology. He directs Stanford Cardiovascular Institute Biomarker and Phenotypic Core Laboratory dedicated to translational studies in cardiovascular medicine. The laboratory focuses on (1) identifying early biomarkers of heart failure and aging, (2) bioengineering approaches to cardiovascular disease modeling and (3) novel informatic approach for the detection and risk stratification of disease. He is involved is several precision medicine initiatives in health including the Project Baseline, the Integrated Personalized Omics Profiling Initiative, the Athletic screening program at Stanford and the Strong-D cardiac rehabilitation initiative in individuals with diabetes mellitus.

  • Bereketeab Haileselassie

    Bereketeab Haileselassie

    Assistant Professor of Pediatrics (Critical Care)

    Current Research and Scholarly InterestsMy laboratory is focused on understanding the cellular mechanisms which mediate end-organ failure in pediatric sepsis. Our current work focuses on determining the role of altered mitochondrial dynamics in sepsis-induced multi-organ dysfunction syndrome (MODS). Specifically, we focus on understanding the mechanisms that mediate derangements in mitochondrial fission and autophagy in sepsis.

  • Frank Hanley

    Frank Hanley

    Lawrence Crowley, M.D., Endowed Professor of Child Health

    Current Research and Scholarly InterestsHis research and clinical work focuses on the development of interventional techniques for fetal and neonatal treatment of congenital heart disease, pulmonary, vascular physiology, and the neurologic impact of open-heart surgery. He developed and pioneered the “unifocalization” procedure, in which a single procedure is used to repair a complex and life-threatening congenital heart defect rather than several staged open-heart surgeries as performed by other surgeons.

  • Robert Harrington

    Robert Harrington

    Arthur L. Bloomfield Professor of Medicine and Professor, by courtesy, of Health Policy

    BioDr. Robert A. Harrington is a cardiologist and the Arthur L. Bloomfield Professor of Medicine and Chair of the Department of Medicine (DOM) at Stanford University. The DOM is the largest department at the Stanford School of Medicine with 14 divisions and more than 700 faculty.

    He was previously the Richard Sean Stack, MD Distinguished Professor and the Director of the Duke Clinical Research Institute (DCRI) at Duke University. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease; building local, national, and international collaborations for the efficient conduct of innovative clinical research; and trying to better understand and improve upon the methodology of clinical research, including the use of technologies to facilitate clinical trials.

    He has authored more than 760 peer-reviewed manuscripts, reviews, book chapters, and editorials. He is a senior editor of the 13th and 14th editions of Hurst’s The Heart, one of the leading textbooks of cardiovascular medicine. He has served as a member and the chair of the US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee.

    Harrington is a member of the American Heart Association’s (AHA) Board of Directors. He served as AHA president-elect, president and immediate past president during 2019–2021. He is an elected member of the Association of American Physicians, the Association of University Cardiologists, and the National Academy of Medicine/Institute of Medicine. In 2016, he was named a Master of the American College of Cardiology. He was awarded the AHA’s Clinical Research Prize in 2017 and AHA Council on Clinical Cardiology (CLCD) Distinguished Achievement Award in 2022. In 2022, he was awarded the Stokes Medal from the Irish Cardiac Society.

    Harrington received his BA in English at the College of the Holy Cross in Worcester, Massachusetts. He attended Dartmouth Medical School and received his MD from Tufts University School of Medicine in Boston. He did his internship and residency and served as the chief resident in internal medicine at the University of Massachusetts Medical Center in Worcester. He trained in cardiology, interventional cardiology, and clinical research (Duke Databank for Cardiovascular Disease) at Duke University Medical Center in Durham, North Carolina, where he was a faculty member from 1993–2012 before joining the Stanford University faculty in 2012.

    Interested in innovative learning tools, Harrington can be followed on Twitter @HeartBobH and on a monthly podcast on theheart.org.

  • E. John Harris Jr.

    E. John Harris Jr.

    Professor of Surgery (Vascular), Emeritus

    Current Research and Scholarly InterestsI am interested in thrombosis and the role of thrombin and its receptor in venous wall remodeling following venous thrombosis. I am also interested in vascular hemodynamics and the use of ultrasound, MRI and computational modeling in evaluating arterial flow in exercise conditions.

  • William Haskell

    William Haskell

    Professor (Research) of Medicine, Emeritus

    Current Research and Scholarly InterestsMy major research interests and activities over the next several years will focus on the development and evaluation of the objective measurement of physical activity in free-living populations using a variety of sensing devices and mobile phones for data collection and processing. Also, I will continue to direct the Stanford Heart Network with the major mission being to assist community-based CVD prevention/treatment programs implement more effective heart attack and stroke prevention programs.

  • Paul Heidenreich, MD

    Paul Heidenreich, MD

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly InterestsMy research interests include

    1) The cost-effectiveness of new cardiovascular technologies.
    Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.

    2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.

    3) Outcomes research using existing clinical and administrative datasets.

    4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).

  • H. Craig Heller

    H. Craig Heller

    Lorry I. Lokey/Business Wire Professor

    Current Research and Scholarly InterestsNeurobiology of sleep, circadian rhythms, regulation of body temperature, mammalian hibernation, and human exercise physiology. Currently applying background in sleep and circadian neurobiology the understanding and correcting the learning disability of Down Syndrome.

  • Jill Helms

    Jill Helms

    Professor of Surgery (Plastic & Reconstructive Surgery)

    Current Research and Scholarly InterestsDr. Helms' research interests center around regenerative medicine and craniofacial development.

  • Robert Herfkens

    Robert Herfkens

    Professor of Radiology (Cardiovascular Imaging), Emeritus

    Current Research and Scholarly InterestsImaging of cardiovascular diseases with CT, magnetic resonance imaging and spectroscopy

  • William Hiesinger, MD

    William Hiesinger, MD

    Associate Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)

    BioDr. Hiesinger is a board-certified, fellowship-trained specialist in adult cardiac surgery. He is also an assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.

    Dr. Hiesinger’s clinical focus encompasses the full spectrum of cardiothoracic conditions and treatment approaches, such as heart transplantation, mitral and aortic valve repair, surgical treatment for hypertrophic cardiomyopathy, coronary artery bypass, and complex thoracic aortic procedures. He serves as Surgical Director of the Stanford Mechanical Circulatory Support Program, where he leads and directs the surgical implantation of ventricular assist devices (VADs) in patients with end-stage heart failure.

    The National Institutes of Health and the Thoracic Surgery Foundation have awarded funds to support Dr. Hiesinger’s research. In the Stanford Cardiothoracic Therapeutics and Surgery Laboratory, Dr. Hiesinger's research spans the disciplines of computer science and cardiovascular biology, and he endeavors to build novel foundational deep learning systems designed to better represent and process high-dimensional inputs and apply these systems towards clinical problems. Additionally, his lab investigates bioengineered devices, tissue engineering, and angiogenic cytokine therapy for the treatment of heart failure.

    He has published extensively and his work has appeared in Nature Communications, Nature Machine Intelligence, the Journal of Heart and Lung Transplantation, Circulation Heart Failure, the Journal of Thoracic and Cardiovascular Surgery, Journal of Vascular Surgery, and elsewhere.

    He teaches courses on cardiothoracic surgery skills. He also advises surgeons of the future.

    Dr. Hiesinger has won awards for his research and scholarship, including the Surgical Resident of the Year Award, Jonathan E. Rhoads Research Award, Clyde F. Baker Research Prize, and I.S. Ravdin Prize, all from his alma mater, the University of Pennsylvania. He was a finalist for the Vivien Thomas Young Investigator Award from the American Heart Association.

    Dr. Hiesinger is a member of the American Association For Thoracic Surgery and serves on the Cardiac Surgery Biology Club. He is also a member of the Society of Thoracic Surgeons and serves on the Workforce on Surgical Treatment of End-Stage Cardiopulmonary Disease national committee as well as the American Heart Association Council for Cardiothoracic and Vascular Surgery.

  • Karen G. Hirsch, MD

    Karen G. Hirsch, MD

    Associate Professor of Neurology and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsDr. Karen G. Hirsch cares for critically ill patients with neurologic disorders in the intensive care unit. Dr. Hirsch's research focuses on using continuous and discrete multi-modal data to develop phenotypes and identify signatures of treatment responsiveness in patients with coma after cardiac arrest. She is the Co-PI of PRECICECAP (PRecision Care In Cardiac ArrEst - ICECAP, NINDS R01 NS119825-01) and works closely with collaborators in data science at Stanford and with industry partners to apply machine learning analyses to the complex multi-modal ICU data. Dr. Hirsch also studies neuro-imaging in post-cardiac arrest coma and traumatic brain injury.

    Additional research interests include a broad array of topics and Dr. Hirsch greatly appreciates the importance of team science and collaboration. Along with colleagues in Biomedical Ethics, Dr. Hirsch studies brain death and organ donation with a focus on ethical challenges and prediction models. Along with colleagues in Cardiac Anesthesia and Cardiothoracic Surgery, Dr. Hirsch studies neurologic outcomes in patients on mechanical circulatory support including ECMO.

    Dr. Hirsch is broadly interested in improving neurologic outcomes after acute brain injury and identifying early phenotypes to guide precision medicine in neurocritical care, especially in patients with post-cardiac arrest brain injury.

  • Mark Hlatky, MD

    Mark Hlatky, MD

    Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsMy main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.

  • Rachel Knight Hopper

    Rachel Knight Hopper

    Clinical Associate Professor, Pediatrics - Cardiology

    Current Research and Scholarly InterestsCurrent research interests include:
    PH related to prematurity and bronchopulmonary dysplasia
    Right heart failure in children with pulmonary hypertension, imaging and biomarkers
    Pulmonary hypertension related to congenital diaphragmatic hernia
    Pulmonary vein stenosis in infants and children
    Pulmonary hypertension in children with congenital heart disease
    Clinical trials in children with PH

  • Benjamin Davies Horne

    Benjamin Davies Horne

    Adjunct Clinical Associate Professor, Medicine - Cardiovascular Medicine

    BioDr. Benjamin Horne is a Clinical Associate Professor (Affiliated) who is based at the Intermountain Medical Center Heart Institute in Salt Lake City, UT, where he serves as the Director of Cardiovascular and Genetic Epidemiology. His doctoral training (PhD) in genetic epidemiology was completed at the University of Utah and he holds masters degrees in public health and in biostatistics. Dr. Horne is a fellow of the American Heart Association and a fellow of the American College of Cardiology. Dr. Horne’s research focuses on population health and precision medicine, including evaluating the genetic epidemiology of heart diseases, developing and implementing clinical decision tools for personalizing medical care, discovering the human health effects of intermittent fasting, and studying the influences of air pollution on major adverse health events.

  • Ngan F. Huang

    Ngan F. Huang

    Associate Professor of Cardiothoracic Surgery (Cardiothoracic Surgery Research) and, by courtesy, of Chemical Engineering

    Current Research and Scholarly InterestsDr. Huang's laboratory aims to understand the chemical and mechanical interactions between extracellular matrix (ECM) proteins and pluripotent stem cells that regulate vascular and myogenic differentiation. The fundamental insights of cell-matrix interactions are applied towards stem cell-based therapies with respect to improving cell survival and regenerative capacity, as well as engineered vascularized tissues for therapeutic transplantation.